Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Resmed (NYSE: RMD) announced that Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Resmed (NYSE: RMD) announced that Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at approximately 10:30 a.m. PST in San Francisco.
The company said a live, audio-only webcast will be available via the investor website investor.resmed.com. An audio replay will be posted about 24 hours after the live event and remain accessible for 30 days.
Details
News Market Reaction – RMD
On Dec 19, the first trading day after this news, RMD closed 0.99% above the previous close.
Data tracked by StockTitan Argus for the Dec 19 session.
Key Figures
- Conference edition
- 44th annual
- J.P. Morgan Healthcare Conference appearance in January 2026
- Presentation time
- 10:30 a.m. PST
- RMD session at J.P. Morgan Healthcare Conference on Jan 12, 2026
- Webcast replay window
- 30 days
- Replay availability after the conference presentation
- Q1 FY26 revenue
- $1.336B
- Quarter ended September 30, 2025; up 9% year-over-year
- Q1 FY26 gross margin
- 61.5%
- Reported gross margin, up 290 bps year-over-year
- Q1 FY26 net income
- $348.5M
- Quarter ended September 30, 2025
- Dividend per share
- $0.60
- Quarterly cash dividend declared in October 2025 8-K
- Sleep apnea burden
- 1 billion people
- Global OSA prevalence cited in Sleep Institute launch
Historical Context
-
FDA clearance for AI-enabled Smart Comfort CPAP personalization feature.
-
Q1 FY26 results with revenue and margin expansion plus dividend and buybacks.
-
Announcement of timing and access details for upcoming Q1 FY26 earnings call.
-
Participation announcement for Bank of America Global Healthcare Conference 2025.
-
Launch of Sleep Institute to advance global sleep health research and awareness.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, beginning at approximately 10:30 a.m. (Pacific Standard Time) in San Francisco, CA.
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
| For investors +1 858.221.3304 investorrelations@resmed.com | For media +1 619.510.1281 news@resmed.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.